Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003068567 | SCV003454774 | uncertain significance | Glucose-6-phosphate transport defect | 2020-12-04 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid with asparagine at codon 193 of the SLC37A4 protein (p.Asp193Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SLC37A4-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004070447 | SCV005017808 | uncertain significance | Inborn genetic diseases | 2023-11-21 | criteria provided, single submitter | clinical testing | The p.D193N variant (also known as c.577G>A), located in coding exon 3 of the SLC37A4 gene, results from a G to A substitution at nucleotide position 577. The aspartic acid at codon 193 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |